Keywords: Antiretroviral therapy; CD4; HIV-1; HIV-2; MRCP; seroconversion;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AIDS; acquired immune deficiency syndrome; ALV; avian leukosis virus; AMV; avian myeloblastosis virus; APOBEC; apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like; ASLV; avian sarcoma leukosis virus; AZT; 3â² -azido-3â² -deoxythymidine; BIV;
Keywords: HIV-2; Reverse transcriptase; Drug resistance; Protease; Integrase; Entry inhibitors
Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads
Keywords: HIV-2; Culture; CD44; Micro-beads; Purification;
Modulation of the NF-κB signaling pathway by the HIV-2 envelope glycoprotein and its incomplete BST-2 antagonism
Keywords: HIV; human immunodeficiency virus; Env; envelope glycoprotein; BST-2; Bone Marrow Stromal Cell Antigen 2; NF-κB; nuclear factor kappa-light-chain-enhancer of activated B cells; IκBs; inhibitors of κB proteins; IKKs; IκB kinases; HIV; HIV-2; Env; Envel
The role of SAMHD1 expression and its relation to HIV-2 (Vpx) gene production
Keywords: HIV-1; HIV-2; SAMHD1; Vpx protein; Macrophages;
The discovery of novel diarylpyri(mi)dine derivatives with high level activity against a wide variety of HIV-1 strains as well as against HIV-2
Keywords: HIV-1; HIV-2; NNRTIs; DAPY; Drug design; Entrance channel;
Contribution of the gp120 V3 loop to envelope glycoprotein trimer stability in primate immunodeficiency viruses
Keywords: Hydrophobic patch; V3 loop; gp120; HIV-1; HIV-2; Simian immunodeficiency virus (SIV); Primate immunodeficiency viruses (PIV);
Clinical validation of a novel diagnostic HIV-2 total nucleic acid qualitative assay using the Abbott m2000 platform: Implications for complementary HIV-2 nucleic acid testing for the CDC 4th generation HIV diagnostic testing algorithm
Keywords: HIV-2; Diagnostic; Qualitative; Total nucleic acid; DNA/RNA; PCR;
HIV-1 Sequence Necessary and Sufficient to Package Non-viral RNAs into HIV-1 Particles
Keywords: HIV-1; human immunodeficiency virus type 1; HIV-2; human immunodeficiency virus type 2; RSV; Rous sarcoma virus; BLV; bovine leukemia virus; MPMV; Mason Pfizer monkey virus; UTR; untranslated region; MA; matrix; CA; capsid; NC; nucleocapsid; TAR; trans-ac
Detection and differentiation of HIV-2 using the point-of-care Alere q HIV-1/2 Detect nucleic acid test
Keywords: HIV-2; Diagnosis; Point-of-care; Nucleic acid test; Alere q HIV-1/2 Detect; Qualitative;
Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra
Keywords: HIV-1; human immunodeficiency virus type-1; m/bp; mutations/base pair; RT; reverse transcriptase; ADAR; adenosine deaminase acting on RNA; HIV-2; human immunodeficiency virus type-2; SSCS; single-strand consensus sequencing; MOI; multiplicity of infection
Hiv-2 molecular epidemiology
Keywords: HIV-2; Epidemiology; West Africa; Genetic diversity;
Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated
Keywords: HIV-2; Dendritic cells; Virus capture; Trans infection; CD169; GM3; Cell-associated virus transfer;
Metabolic profiling during HIV-1 and HIV-2 infection of primary human monocyte-derived macrophages
Keywords: HIV-1; HIV-2; Metabolites; TCA; Glycolysis; Macrophages; LC–MS/MS
Spectroscopic investigation of auranofin binding to zinc finger HIV-2 nucleocapsid peptides
Keywords: Auranofin; 1-Thio-β-d-glucopyranosatotriethylphosphine gold-2,3,4,6-tetraacetate; TCEP; Tris(2-carboxyethyl)phosphine hydrochloride; PAR; 4-(pyridyl-2-azo)-resorcinol; Auranofin; Zinc finger; HIV-2; Mass spectrometry; CD; Fluorescence;
Dolutegravir for the treatment of HIV-2 infection
Keywords: HIV-2; Dolutegravir; Raltegravir; Antiretroviral therapy; Drug resistance;
How does the humoral response to HIV-2 infection differ from HIV-1 and can this explain the distinct natural history of infection with these two human retroviruses?
Keywords: Neutralising antibody; HIV-1; HIV-2; Viral diversity; Immune escape;
Impact of HIV-1, HIV-2, and HIV-1+2 dual infection on the outcome of tuberculosis
Keywords: Tuberculosis; HIV-1; HIV-2; Mortality
Pre-steady state kinetic analysis of HIV-1 reverse transcriptase for non-canonical ribonucleoside triphosphate incorporation and DNA synthesis from ribonucleoside-containing DNA template
Keywords: rNTP; ribonucleotide; rNMP; ribonucleoside monophosphate; dNMP; deoxyribonucleoside monophosphate; dNTP; deoxyribonucleotide; HIV-1; Human Immunodeficiency Virus 1; RT; HIV-1 reverse transcriptase; SIV; Simian Immunodeficiency Virus; HIV-2; Human Immunode
Stoichiometric parameters of HIV-1 entry
Keywords: HIV-2; gp120; Env; Entry; Relative infectivity; CD4; CCR5; CXCR4;
Mutational analysis of HIV-2 Vpx shows that proline residue 109 in the poly-proline motif regulates degradation of SAMHD1
Keywords: HIV-2; Vpx; SAMHD1; Poly-proline;
Design, synthesis of new β-carboline derivatives and their selective anti-HIV-2 activity
Keywords: β-Carboline; HIV-1; HIV-2; Reverse transcriptase;
Reference panel of cloned HIV-2 plasmid DNA for nucleic acid assay development, evaluation, and quality monitoring
Keywords: HIV-2; Clone; Plasmid; HIV-2 group; Real-time PCR; NAT
Discriminatory capacity between HIV-1 and HIV-2 of the new rapid confirmation assay Geenius
Keywords: HIV-1; HIV-2; Differentiation; INNO-LIA; Geenius HIV 1/2 Confirmatory Assay;
Short communicationVirological characterization of HIV-2 vpx gene mutants in various cell systems
Keywords: HIV-2; SIVmac; Vpx; Target protein; Natural target cells;
Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approach
Keywords: HIV-1; HIV-2; DAPY; Anti-HIV activities; Structure–activity relationships; Molecular modelingAIDS, acquired immunodeficiency syndrome; HIV-1, human immunodeficiency virus type-1; HAART, highly active antiretroviral therapy; NNRTIs, non-nucleoside reverse
Clinical performance of the Multispot HIV-1/HIV-2 rapid test to correctly differentiate HIV-2 from HIV-1 infection in screening algorithms using third and fourth generation assays and to identify cross reactivity with the HIV-1 Western Blot
Keywords: Multispot; HIV-2; HIV testing algorithms; Nucleic acid amplification tests; Orthogonal supplemental testing;
Multiple platforms of a HIV-2 derived lentiviral vector for expanded utility
Keywords: Lentivirus vector; HIV-2; Multiformat LV; Multiple cloning sites; T/A cloning; Transgene expression;
Evaluation of five simple rapid HIV assays for potential use in the Brazilian national HIV testing algorithm
Keywords: HIV-1; HIV-2; HIV diagnosis; Immune assays;
Highly sensitive plasma RNA quantification by real-time PCR in HIV-2 group A and group B infection
Keywords: HIV-2; Viral load; Natural history;
Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I
Keywords: EIA; enzyme immunoassay; WB; Western blot; IFA; immunofluorescence assay; CLSI; Clinical and Laboratory Standards Institute; HIV; human immunodeficiency virus; Ab; antibody; Ag; antigen; NAT; nucleic acid testing; FDA; Food and Drug Administration; r-gp;
Validation and clinical use of a sensitive HIV-2 viral load assay that uses a whole virus internal control
Keywords: HIV-2; Viral load; Clinical assay; Real time RT-PCR;
Translation initiation is driven by different mechanisms on the HIV-1 and HIV-2 genomic RNAs
Keywords: 4E-BP; eIF4E-binding protein; BMH; branched multiple hairpins; CrPV; cricket paralysis virus; CSFV; Classical Swine Fever Virus; DIS; dimerization site; eIF; eukaryotic initiation factor; EMCV; encephalomyocarditis virus; FMDV; foot-and-mouth-disease viru
Natural history of HIV and AIDS
Keywords: cART; CD4; HIV-1; HIV-2; HIV seroconversion
Clinical predictors cannot replace biological predictors in HIV-2 infection in a community setting in West Africa
Keywords: HIV-2; Africa; Body mass index; Mortality; Cohort;
Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established H
Keywords: CDC, Centers for Disease Control and Prevention; IA, immunoassay; IFA, immunofluorescence assay; NAAT, nucleic acid amplification test; WB, Western blotHIV testing; Algorithm; United States; HIV-2; Nucleic acid amplification test
Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the Multispot HIV-1/HIV-2 Rapid Test for classifying HIV-1 and HIV-2 infections
Keywords: HIV-1; HIV-2; HIV subtype differentiation; HIV-1/HIV-2 Rapid Test; Supplemental HIV testing; HIV-1 Western blot criteria
Evaluation of an alternative supplemental testing strategy for HIV diagnosis by retrospective analysis of clinical HIV testing data
Keywords: HIV-1; HIV-2; Algorithm; Diagnostic; Supplemental test
Strategies to quantify unspliced and multiply spliced mRNA expression in HIV-2 infection
Keywords: AIDS; HIV-2; Unspliced mRNA; Multiply spliced mRNA; HIV-2 replication; One-step RT-qPCR;
Cellular entry via an actin and clathrin-dependent route is required for Lv2 restriction of HIV-2
Keywords: HIV-2; Cell entry; Lv2; Endocytosis;
Evaluation of four rapid tests for diagnosis and differentiation of HIV-1 and HIV-2 infections in Guinea-Conakry, West Africa
Keywords: Rapid tests; HIV-1; HIV-2; discrimination; Guinea-Conakry;
Higher mortality in HIV-2/HTLV-1 co-infected patients with pulmonary tuberculosis in Guinea-Bissau, West Africa, compared to HIV-2-positive HTLV-1-negative patients
Keywords: HTLV-1; HIV-1; HIV-2; CD4; Tuberculosis; Mortality;
Baseline characteristics, response to and outcome of antiretroviral therapy among patients with HIV-1, HIV-2 and dual infection in Burkina Faso
Keywords: HIV-1; HIV-2; Antiretroviral therapy; Treatment response; Treatment outcome; Burkina Faso;
Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system
Keywords: HIV-1 Group O; HIV-2; Multiplex testing; Sensitivity; Specificity
Prevalence and risk determinants of HIV-1 and HIV-2 infections in pregnant women in Bissau
Keywords: HIV-1; HIV-2; Epidemiology; Pregnant women; Guinea-Bissau
HIV-2 capsids distinguish high and low virus load patients in a West African community cohort
Keywords: HIV-2; Capsid; TRIM5α
Coreceptor usage by HIV-1 and HIV-2 primary isolates: The relevance of CCR8 chemokine receptor as an alternative coreceptor
Keywords: HIV-1; HIV-2; HIV coreceptor; CCR8; Chemokine receptor; Primary isolate; Pathogenesis; Cellular receptor; Entry inhibitor; Antiretroviral therapy
Anti-HIV and antiplasmodial activity of original flavonoid derivatives
Keywords: Flavonoid; Chalcone; Plasmodium falciparum; HIV-1; HIV-2; Selectivity index
HIV: the virus
Keywords: AIDS; HIV-1; HIV-2; pathogenesis; viral replication